This product(s) resides on a APICMO contract.
The ability to produce, synthesize and manufacture large quantities of 3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-amine (83255-86-1) with quality control system under CGMP manufacturing
A number of 3,4-disubstituted pyrazolo[3,4-d]pyrimidine ribonucleosides were synthesized and tested for their biological activity. Glycosylation of persilylated as well as nonsilylated 3-bromoallopurinol with 1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose (4) provided the key intermediate 3-bromo-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidin -4(5H)-one (5a). Similar glycosylations of 3-cyanoallopurinol and 3-(methylthio)allopurinol furnished the corresponding protected N-1 glycosyl derivatives (5b and 5c). Debenzoylation of these nucleosides (5a-c) gave the corresponding 3-bromo, 3-cyano-, and 3-(methylthio)allopurinol nucleosides (6a-c). The site of glycosylation and anomeric configuration of 6a and 6c were assigned on the basis of spectral studies as well as conversion to allopurinol ribonucleoside, whereas the structural assignment of 6b was made by single-crystal X-ray analysis. Conventional functional group transformation of 5a and 5b provided a number of novel 3-substituted allopurinol nucleosides, which included 18a-d. Glycosylation of 4-amino-3-bromopyrazolo[3,4-d]pyrimidine with 4 and subsequent debenzoylation gave 3-bromo-4-aminopyrazolo[3,4-d]pyrimidine ribonucleoside from which 3,4-diamino-β-D-ribofuranosylpyrazolo[3,4-d]pyrimidine was obtained by amination. Thiation of 5b, followed by deblocking, gave 3-cyanothiopurinol ribonucleoside (20). All of these compounds were tested in vitro against certain viruses, tumor cells, and the parasite Leishmania tropica. Among the 3-substituted allopurinol nucleosides, 18b and 18c showed significant activity against Para 3 virus and were found to be potent inhibitors of growth of L1210 and P388 leukemia. Compound 20 exhibited the most significant broad-spectrum in vitro antiviral and antitumor activity. 3-Bromoallopurinol ribonucleoside (6a) was found to be more active than allopurinol ribonucleoside against Leishmania tropica within human macrophages in vitro.
This product(s) resides on a APICMO contract. If you are viewing this page as a non-registered user, the price(s) displayed is List Price. To view your pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. To place an order, contact APICMO Customer Service.
3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-amine (83255-86-1) Specifications
|CAS Min %||97%|
|CAS Max %||100%|
|Chemical Name or Material||3-Bromo-1h-pyrazolo[3,4-d]pyrimidin-4-amine|
|Physical Form||Powder or Chunks|
|Molecular Weight (g/mol)||214.026|
3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-amine (83255-86-1) Safety and Handling
(83255-86-1) Hazard description:
♦ Causes skin irritation
♦ Causes serious eye irritation.
3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-amine Precautionary statement:
♦ Wash hands and face thoroughly after handling.
♦ Wear protective gloves, eye protection
♦ If on skin: Wash with plenty of soap and water. If skin irritation occurs: Get medical advice or attention. Take off contaminated clothing and wash it before reuse.
♦ If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
WARNING: The information provided on this web site was developed in compliance with European Union (EU) regulations and is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guide for safe handling and use. It is not to be considered as either a warranty or quality specification.
3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-amine (83255-86-1) Articles
Bromopyrazolo[3,4-d]pyrimidine 2′-deoxy-2′-fluoro-β-D-arabinonucleosides: Modified DNA constituents with an unusually rigid sugar N-conformation
Journal of Organic Chemistry 2003
Synthesis, anticancer evaluation, and molecular docking studies of some novel 4,6-disubstituted pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors
Bioorganic Chemistry 2018
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-amine (83255-86-1) Bulk Ordering & Pricing:
Need larger quantities for your development, manufacturing or research applications?